Your browser doesn't support javascript.
loading
Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts.
Theocharides, A P A; Dobson, S M; Laurenti, E; Notta, F; Voisin, V; Cheng, P-Y; Yuan, J S; Guidos, C J; Minden, M D; Mullighan, C G; Torlakovic, E; Dick, J E.
Afiliación
  • Theocharides AP; 1] Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada [2] Institute of Medical Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada [3] Division of Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Dobson SM; 1] Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada [2] Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Laurenti E; 1] Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada [2] Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Notta F; 1] Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada [2] Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Voisin V; Pathway and Network Analyses for OICR Cancer Stem Cell Research, Terrence Donnelly Centre for Cellular and Biomedical Research, University of Toronto, Ontario, Canada.
  • Cheng PY; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Yuan JS; Developmental & Stem Cell Biology Program, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
  • Guidos CJ; Developmental & Stem Cell Biology Program, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
  • Minden MD; 1] Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada [2] Institute of Medical Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada [3] Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto,
  • Mullighan CG; St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Torlakovic E; 1] Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada [2] Department of Laboratory Hematology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
  • Dick JE; 1] Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada [2] Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Leukemia ; 29(1): 177-87, 2015 Jan.
Article en En | MEDLINE | ID: mdl-24791856
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Proteínas de Fusión bcr-abl / Factor de Transcripción Ikaros / Genes Dominantes Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Proteínas de Fusión bcr-abl / Factor de Transcripción Ikaros / Genes Dominantes Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido